サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1643996

POC HbA1C検査の世界市場：2033年までの機会と戦略

POC HbA1C Testing Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 293 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
POC HbA1C検査の世界市場：2033年までの機会と戦略
出版日: 2025年01月27日
発行: The Business Research Company
ページ情報: 英文 293 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のPOC HbA1C検査市場は2018年に5億7,994万米ドルと評価され、CAGR7.00％以上で2023年まで成長しました。

個別化医療の採用増加

個別化医療の採用の高まりがPOC HbA1C検査市場の成長を支えました。個別化医療は、精密医療や個別化医療とも呼ばれ、患者一人ひとりの特性に合わせた治療や介入を目指す医療へのアプローチです。POC HbA1C検査装置はその場で迅速に結果を出すため、ヘルスケア専門家は糖尿病治療計画を迅速に調整することができます。これは、継続的なモニタリングと各患者固有の要件に合わせた修正を頻繁に必要とする個別化医療のアプローチをサポートするものです。例えば、科学者、患者、医療提供者を代表し、患者と医療制度に利益をもたらす個別化医療の理解と普及を推進する米国の組織である個別化医療連合（PMC）によると、2022年10月には、複数の種類のがん、遺伝性希少疾患、さまざまな慢性疾患や感染症の患者向けに、75,000を超える遺伝子検査製品と300の個別化医薬品が市場に出回っていました。さらに、個別化医薬品は2022年に米国食品医薬品局が承認した新薬の34％を占め、過去8年間はいずれも承認の25％以上を占めています。したがって、個別化医療の採用の高まりは、歴史的な期間中のPOC HbA1C検査市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

  • POC HbA1C検査-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • POC HbA1C検査市場定義とセグメンテーション
  • 製品タイプ別の市場セグメンテーション
    • 機器
    • 消耗品
  • 技術別の市場セグメンテーション
    • イオン交換HPLC
    • 酵素アッセイ
    • アフィニティバインディング
    • 免疫測定
  • エンドユーザー別の市場セグメンテーション
    • 病院
    • 医師オフィス/外来センター
    • 在宅ケア
    • その他のエンドユーザー

第7章 主要な市場動向

  • 迅速かつ正確なHbA1C検査を実現する高度なポイントオブケアソリューション
  • 次世代ポイントオブケアデバイスの発売により糖尿病の管理と早期診断が強化される
  • 月経血を用いた革新的なポイントオブケアHbA1C検査システムがFDAの承認を取得
  • 主要企業間の戦略的提携と買収により製品ラインナップを強化

第8章 POC HbA1C検査市場- マクロ経済シナリオ

  • COVID-19の影響： POC HbA1C検査市場
  • ウクライナ戦争の影響： POC HbA1C検査市場
  • 高インフレの影響： POC HbA1C検査市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018-2023
    • 市場促進要因、2018-2023
    • 市場抑制要因、2018-2023
  • 市場成長予測、2023-2028、2033F
    • 市場促進要因、2023-2028
    • 市場抑制要因、2023-2028

第10章 世界のPOC HbA1C検査市場：セグメンテーション

  • 世界のPOC HbA1C検査市場：製品タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のPOC HbA1C検査市場：技術別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のPOC HbA1C検査市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 POC HbA1C検査市場：地域・国別分析

  • 世界のPOC HbA1C検査市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のPOC HbA1C検査市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Siemens Healthineers AG
  • F. Hoffman-La Roche Ltd
  • Bio-Rad Laboratories, Inc
  • Menarini Group
  • Danaher Corporation

第20章 その他の大手企業と革新的企業

  • i-SENS, Inc
  • Tosoh Corp
  • ARKRAY Inc
  • Abbott Laboratories
  • LumoraDX
  • PTS Diagnostics
  • EKF Diagnostics
  • SD Biosensor
  • Getein Biotech Inc
  • Sysmex Corporation
  • Diazyme Laboratories
  • HUMAN Diagnostics Worldwide
  • Trinity Biotech PLC
  • Randox Laboratories Ltd
  • Osang Healthcare

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Roche Holding AG Acquired LumiraDx
  • Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
  • QIAGEN N.V. Acquired BLIRT S.A.

第24章 機会と戦略

  • 世界のPOC HbA1C検査市場2028：新たな機会を提供する国
  • 世界のPOC HbA1C検査市場2028：新たな機会を提供するセグメント
  • 世界のPOC HbA1C検査市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 POC HbA1C検査市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1459

Point-of-care (POC) HbA1C testing refers to the immediate measurement of glycated hemoglobin levels at or near the site of patient care, such as clinics, physician offices, or even at home. This testing is primarily utilized by healthcare professionals, including physicians, nurses and diabetes educators, to monitor and manage diabetes by assessing a patient's average blood glucose levels over the past two to three months.

The POC HbA1C testing market consists of sales, by entities (organizations, sole traders and partnerships), of POC HbA1C testing devices used to assess glycemic control over 2 to 3 months in patients with HbA1C type I or type II diabetes mellitus. Diabetes is a chronic disease which occurs either when inadequate amounts of insulin are produced by the pancreas or when the body cannot use the insulin it produces effectively. Insulin is a hormone that regulates blood sugar.

The global POC HbA1C testing market was valued at $579.94 million in 2018 which grew up till 2023 at a compound annual growth rate (CAGR) of more than 7.00%.

Rising Adoption Of Personalized Medicine

The rising adoption of personalized medicine supported the growth of the POC HbA1C testing market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. POC HbA1C testing devices deliver quick, on-site results, allowing healthcare professionals to promptly adjust diabetes treatment plans. This supports the personalized medicine approach, which frequently necessitates ongoing monitoring and modifications tailored to each patient's unique requirements. For instance, in October 2022, according to the Personalized Medicine Coalition(PMC), a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, more than 75,000 genetic testing products and 300 personalized medicines were present on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, personalized medicines accounted for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the rising adoption of personalized medicine supported the growth of the POC HbA1C testing market during the historic period.

FDA Approval For Innovative Point-Of-Care HbA1C Testing System Using Menstrual Blood

Major companies in the POC HbA1C testing market are focusing on developing innovative products with enhanced point-of-care testing capabilities to improve patient convenience and provide quicker, more accurate results. Point-of-care testing capability refers to diagnostic tests conducted at or near the site of patient care, allowing for rapid results and immediate clinical decision-making. It enables healthcare providers to perform tests outside traditional laboratories, often at the patient's bedside or in outpatient settings. In January 2024, Qvin, a US-based biotechnology company that aims to make health insights accessible to people who menstruate, received approval from U.S. Food and Drug Administration (FDA) for Q-Pad A1c Test System, which allows for the measurement of hemoglobin A1c (HbA1C) using menstrual blood. This innovative system is designed for individuals aged 18 and older and consists of a Q-Pad, an unscented menstrual pad with an embedded blood collection strip (Q-Strip) and a kit that includes two Q-Pads, a return sample container and a prepaid mailing pouch.

The global POC HbA1C testing market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up 81.2% of the total market in 2023.

POC HbA1C Testing Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global POC HbA1C testing market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for POC HbA1C testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The POC HbA1C testing market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider POC HbA1C testing market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type of product, by technology and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the POC HbA1C testing market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type of product, by technology and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for POC HbA1C testing providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type Of Product: Instruments; Consumables
  • 2) By Technology: Ion-Exchange HPLC; Enzymatic Assay; Affinity Binding; Immunoassay
  • 3) By End User: Hospitals; Physician Office/Outpatient Center; Home Care; Other End Users
  • Companies Mentioned: Siemens Healthineers AG; F. Hoffmann-La Roche AG; Bio-Rad Laboratories, Inc.; Menarini Group; Danaher Corporation
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; POC HbA1C testing indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 POC HbA1C Testing - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 POC HbA1C Testing Market Definition And Segmentations
  • 6.4 Market Segmentation By Type Of Product
    • 6.4.1 Instruments
    • 6.4.2 Consumables
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Ion-Exchange HPLC
    • 6.5.2 Enzymatic Assay
    • 6.5.3 Affinity Binding
    • 6.5.4 Immunoassay
  • 6.6 Market Segmentation By End User
    • 6.6.1 Hospitals
    • 6.6.2 Physician Office/Outpatient Center
    • 6.6.3 Home Care
    • 6.6.4 Other End Users

7 Major Market Trends

  • 7.1 Advanced Point-Of-Care Solution For Rapid And Accurate HbA1C Testing
  • 7.2 Launch Of Next-Generation Point-Of-Care Device Enhances Diabetes Management And Early Diagnosis
  • 7.3 FDA Approval For Innovative Point-Of-Care HbA1C Testing System Using Menstrual Blood
  • 7.4 Strategic Partnerships And Acquisition Among Major Players To Enhance Product Offerings

8 POC HbA1C Testing Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The POC HbA1C Testing Market
  • 8.2 Impact Of The War In Ukraine On The POC HbA1C Testing Market
  • 8.3 Impact Of High Inflation On The POC HbA1C Testing Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global POC HbA1C Testing Market Segmentation

  • 10.1 Global POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 POC HbA1C Testing Market, Regional and Country Analysis

  • 11.1 Global POC HbA1C Testing Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global POC HbA1C Testing Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific POC HbA1C Testing Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.1 China POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.2 Australia POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 South Korea POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate tax structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe POC HbA1C Testing Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.1 Germany Market
  • 13.11 Germany POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.2 Italy POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major companies
  • 14.2 Eastern Europe POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe POC HbA1C Testing Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America POC HbA1C Testing Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.1 USA POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.1 Region Information
    • 16.1.2 Market Information
    • 16.1.3 Background Information
    • 16.1.4 Government Initiatives
    • 16.1.5 Regulations
    • 16.1.6 Regulatory Bodies
    • 16.1.7 Major Associations
    • 16.1.8 Taxes Levied
    • 16.1.9 Corporate Tax Structure
    • 16.1.10 Investments
    • 16.1.11 Major Companies
  • 16.2 South America POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 Brazil Market
  • 16.6 Brazil POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.7 Brazil POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa POC HbA1C Testing Market, Segmentation By Type Of Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa POC HbA1C Testing Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa POC HbA1C Testing Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Siemens Healthineers AG
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 F. Hoffman-La Roche Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Bio-Rad Laboratories, Inc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Financial Overview
  • 19.5 Menarini Group
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Danaher Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 i-SENS, Inc
    • 20.1.1 Company Overview
    • 20.1.2 Products and Services
  • 20.2 Tosoh Corp
    • 20.2.1 Company Overview
    • 20.2.2 Products and Services
  • 20.3 ARKRAY Inc
    • 20.3.1 Company Overview
    • 20.3.2 Products and Services
  • 20.4 Abbott Laboratories
    • 20.4.1 Company Overview
    • 20.4.2 Products and Services
  • 20.5 LumoraDX
    • 20.5.1 Company Overview
    • 20.5.2 Products and Services
  • 20.6 PTS Diagnostics
    • 20.6.1 Company Overview
    • 20.6.2 Products and Services
  • 20.7 EKF Diagnostics
    • 20.7.1 Company Overview
    • 20.7.2 Products and Services
  • 20.8 SD Biosensor
    • 20.8.1 Company Overview
    • 20.8.2 Products and Services
  • 20.9 Getein Biotech Inc
    • 20.9.1 Company Overview
    • 20.9.2 Products and Services
  • 20.1 Sysmex Corporation
    • 20.10.1 Company Overview
    • 20.10.2 Products and Services
  • 20.11 Diazyme Laboratories
    • 20.11.1 Company Overview
    • 20.11.2 Products and Services
  • 20.12 HUMAN Diagnostics Worldwide
    • 20.12.1 Company Overview
    • 20.12.2 Products and Services
  • 20.13 Trinity Biotech PLC
    • 20.13.1 Company Overview
    • 20.13.2 Products and Services
  • 20.14 Randox Laboratories Ltd
    • 20.14.1 Company Overview
    • 20.14.2 Products and Services
  • 20.15 Osang Healthcare
    • 20.15.1 Company Overview
    • 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Roche Holding AG Acquired LumiraDx
  • 23.2 Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
  • 23.3 QIAGEN N.V. Acquired BLIRT S.A.

24 Opportunities And Strategies

  • 24.1 Global POC HbA1C Testing Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global POC HbA1C Testing Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global POC HbA1C Testing Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 POC HbA1C Testing Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer